These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 2882256)
1. Breast cancer screening. Lancet; 1987 Apr; 1(8537):859. PubMed ID: 2882256 [No Abstract] [Full Text] [Related]
2. [Cost-effectiveness analysis of breast cancer screening with mammography]. Iinuma T Nihon Rinsho; 2007 Jun; 65 Suppl 6():226-8. PubMed ID: 17682158 [No Abstract] [Full Text] [Related]
3. Ultrasound and mammography for breast cancer screening. Magee BD JAMA; 2008 Oct; 300(13):1514; author reply 1515. PubMed ID: 18827204 [No Abstract] [Full Text] [Related]
4. [Mammography screening in Germany: how, when and why?]. Bick U Rofo; 2006 Oct; 178(10):957-69. PubMed ID: 17021975 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women. Barfar E; Rashidian A; Hosseini H; Nosratnejad S; Barooti E; Zendehdel K Arch Iran Med; 2014 Apr; 17(4):241-5. PubMed ID: 24724599 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. Plevritis SK; Kurian AW; Sigal BM; Daniel BL; Ikeda DM; Stockdale FE; Garber AM JAMA; 2006 May; 295(20):2374-84. PubMed ID: 16720823 [TBL] [Abstract][Full Text] [Related]
7. Cost analysis of aggressive breast cancer screening. Moskowitz M; Fox SH Radiology; 1979 Jan; 130(1):253-6. PubMed ID: 103136 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands. Sankatsing VD; Heijnsdijk EA; van Luijt PA; van Ravesteyn NT; Fracheboud J; de Koning HJ Int J Cancer; 2015 Oct; 137(8):1990-9. PubMed ID: 25895135 [TBL] [Abstract][Full Text] [Related]
9. The use of life expectancy in cancer screening guidelines. Moving with caution from model-based evidence to evidence-based guidelines. Lantz PM; Ubel PA J Gen Intern Med; 2005 Jun; 20(6):552-3. PubMed ID: 15987335 [No Abstract] [Full Text] [Related]
10. Comments and response on the USPSTF recommendation on screening for breast cancer. Begg CB Ann Intern Med; 2010 Apr; 152(8):540-1; author reply 543-4. PubMed ID: 20157101 [No Abstract] [Full Text] [Related]
11. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences. Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942 [TBL] [Abstract][Full Text] [Related]
12. The feasibility of breast cancer screening. Health Technol; 1987; 1(1):26-37. PubMed ID: 10311915 [No Abstract] [Full Text] [Related]
13. Early detection of breast cancer in women. Humphrey LL; Ballard DJ Prim Care; 1989 Mar; 16(1):115-32. PubMed ID: 2495540 [TBL] [Abstract][Full Text] [Related]
14. Comparison of costs and benefits of breast cancer screening with mammography, ultrasonography, and MRI. Feig S Obstet Gynecol Clin North Am; 2011 Mar; 38(1):179-96, ix. PubMed ID: 21419333 [TBL] [Abstract][Full Text] [Related]
15. Mammography 1984: challenge to radiology. McLelland R AJR Am J Roentgenol; 1984 Jul; 143(1):1-4. PubMed ID: 6428201 [TBL] [Abstract][Full Text] [Related]
19. The value of mammography screening in women under age 50 years. Eddy DM; Hasselblad V; McGivney W; Hendee W JAMA; 1988 Mar; 259(10):1512-9. PubMed ID: 3123720 [TBL] [Abstract][Full Text] [Related]
20. Breast cancer screening for women aged 40 to 49 years--what does the evidence mean for New Zealand? Baker S; Wall M; Bloomfield A N Z Med J; 2005 Aug; 118(1221):U1628. PubMed ID: 16138166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]